Stimulus-dependent activation of NF-kappaB specifies apoptosis or neuroprotection in cerebellar granule cells

Kaltschmidt B, Heinrich M, Kaltschmidt C (2002)
Neuromolecular Med 2(3): 299-309.

Download
No fulltext has been uploaded. References only!
Journal Article | Published | English

No fulltext has been uploaded

Publishing Year
ISSN
PUB-ID

Cite this

Kaltschmidt B, Heinrich M, Kaltschmidt C. Stimulus-dependent activation of NF-kappaB specifies apoptosis or neuroprotection in cerebellar granule cells. Neuromolecular Med. 2002;2(3):299-309.
Kaltschmidt, B., Heinrich, M., & Kaltschmidt, C. (2002). Stimulus-dependent activation of NF-kappaB specifies apoptosis or neuroprotection in cerebellar granule cells. Neuromolecular Med, 2(3), 299-309. doi:10.1385/NMM:2:3:299
Kaltschmidt, B., Heinrich, M., and Kaltschmidt, C. (2002). Stimulus-dependent activation of NF-kappaB specifies apoptosis or neuroprotection in cerebellar granule cells. Neuromolecular Med 2, 299-309.
Kaltschmidt, B., Heinrich, M., & Kaltschmidt, C., 2002. Stimulus-dependent activation of NF-kappaB specifies apoptosis or neuroprotection in cerebellar granule cells. Neuromolecular Med, 2(3), p 299-309.
B. Kaltschmidt, M. Heinrich, and C. Kaltschmidt, “Stimulus-dependent activation of NF-kappaB specifies apoptosis or neuroprotection in cerebellar granule cells”, Neuromolecular Med, vol. 2, 2002, pp. 299-309.
Kaltschmidt, B., Heinrich, M., Kaltschmidt, C.: Stimulus-dependent activation of NF-kappaB specifies apoptosis or neuroprotection in cerebellar granule cells. Neuromolecular Med. 2, 299-309 (2002).
Kaltschmidt, Barbara, Heinrich, M., and Kaltschmidt, Christian. “Stimulus-dependent activation of NF-kappaB specifies apoptosis or neuroprotection in cerebellar granule cells”. Neuromolecular Med 2.3 (2002): 299-309.
This data publication is cited in the following publications:
This publication cites the following data publications:

36 Citations in Europe PMC

Data provided by Europe PubMed Central.

CARD15 variants in patients with sporadic Parkinson's disease.
Bialecka M, Kurzawski M, Klodowska-Duda G, Opala G, Juzwiak S, Kurzawski G, Tan EK, Drozdzik M., Neurosci Res 57(3), 2007
PMID: 17174426
NF-kappaB contributes to 6-hydroxydopamine-induced apoptosis of nigral dopaminergic neurons through p53.
Liang ZQ, Li YL, Zhao XL, Han R, Wang XX, Wang Y, Chase TN, Bennett MC, Qin ZH., Brain Res 1145(), 2007
PMID: 17368433
Pro-apoptotic role of NF-kappaB: implications for cancer therapy.
Radhakrishnan SK, Kamalakaran S., Biochim Biophys Acta 1766(1), 2006
PMID: 16563635
Neuronal activation of NF-kappaB contributes to cell death in cerebral ischemia.
Zhang W, Potrovita I, Tarabin V, Herrmann O, Beer V, Weih F, Schneider A, Schwaninger M., J Cereb Blood Flow Metab 25(1), 2005
PMID: 15678110
The NF-kappaB pathway mediates fenretinide-induced apoptosis in SH-SY5Y neuroblastoma cells.
Hewson QD, Lovat PE, Corazzari M, Catterall JB, Redfern CP., Apoptosis 10(3), 2005
PMID: 15909111
PKR activation in neurodegenerative disease.
Peel AL., J Neuropathol Exp Neurol 63(2), 2004
PMID: 14989595
Microarray analysis of tumor necrosis factor alpha induced gene expression in U373 human glioblastoma cells.
Schwamborn J, Lindecke A, Elvers M, Horejschi V, Kerick M, Rafigh M, Pfeiffer J, Prüllage M, Kaltschmidt B, Kaltschmidt C., BMC Genomics 4(1), 2003
PMID: 14641910
New treatments for diabetic neuropathy: pathogenetically oriented treatment.
Bierhaus A, Humpert PM, Rudofsky G, Wendt T, Morcos M, Hamann A, Nawroth PP., Curr Diab Rep 3(6), 2003
PMID: 14611740

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 12622408
PubMed | Europe PMC

Search this title in

Google Scholar